홈 > 시장보고서 > 의약품 > 바이오의약품

시장보고서

상품코드

1741169

중화 항체 시장 : 항체 유형별, 타겟 바이러스별, 용도별, 최종 사용자별, 판매 채널별, 지역별

Neutralizing Antibody Market, By Antibody Type, By Target Virus, By Application, By End User, By Distribution Channel, By Geography

발행일: 2025년 03월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 중화 항체 시장은 2025년 2,439억 3,000만 달러로 추정되고, 2032년까지 4,345억 8,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 8.6%로 성장할 전망입니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	2,439억 3,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR:	8.60%	2032년 가치 예측	4,345억 8,000만 달러

중화 항체는 자연 면역의 중요한 구성 요소이며, 자연 감염과 백신 접종 모두에 의해 유도됩니다. 이 항체는 바이러스의 특정 부분을 인식하고 바이러스가 세포에 결합하여 감염하는 것을 저지합니다.

시장 역학:

세계의 중화항체 시장은 예측기간 중에 급성장이 예상됩니다. 또한 mAbs 개발을 위한 첨단 기술의 도입은 이 시장의 성장을 가속할 것으로 예측됩니다.

본 조사의 주요 특징

본 보고서에서는 세계의 중화 항체 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터를 바탕으로 세계 중화 항체 시장의 주요 기업 프로파일을 제공합니다.
본 보고서로부터 얻을 수 있는 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
세계의 중화 항체 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
이해관계자는 세계 중화 항체 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 243.93 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 434.58 Bn

Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.

Market Dynamics:

The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.

Key features of the study:

This report provides in-depth analysis of the global neutralizing antibody market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market

Neutralizing Antibody Market Detailed Segmentation:

By Antibody Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
By Target Virus:
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
By Application:
- Therapeutics
- Diagnostics
- Research and Development
By End User:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
By Distribution Channel:
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- COVID-19 Pandemic
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Neutralizing Antibody Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Neutralizing Antibody Market, By Antibody Type, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Bn)
Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Bn)

6. Neutralizing Antibody Market, By Target Virus, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
SARS-CoV-2 (COVID-19)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

7. Neutralizing Antibody Market, By Application, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

8. Neutralizing Antibody Market, By End User, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

9. Neutralizing Antibody Market, By Distribution Channel, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2025,(US$ Billion)

10. Neutralizing Antibody Market, By Region, 2020-2025, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2025,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2025,(US$ Bn)
  - GCC
  - Israel
  - North Africa
  - Central Africa
  - Rest of Middle East & Africa

11. Competitive Landscape

Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Moderna, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioNTech SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sinovac Biotech Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,500

￦ 6,676,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 7,000

￦ 10,385,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,837,000

※ 부가세 별도

중화 항체 시장 : 항체 유형별, 타겟 바이러스별, 용도별, 최종 사용자별, 판매 채널별, 지역별

Neutralizing Antibody Market, By Antibody Type, By Target Virus, By Application, By End User, By Distribution Channel, By Geography

시장 역학:

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 중화 항체 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 중화 항체 시장 : 항체 유형별, 2020-2025년

제6장 중화 항체 시장 : 타겟 바이러스별, 2020-2025년

제7장 중화 항체 시장 : 용도별, 2020-2025년

제8장 중화 항체 시장 : 최종 사용자별, 2020-2025년

제9장 중화 항체 시장 : 판매 채널별, 2020-2025년

제10장 중화항체 시장 : 지역별, 2020-2025년

제11장 경쟁 구도

제12장 섹션